Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Corbus Pharma (CRBP)

Corbus Pharma (CRBP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 186,562
  • Shares Outstanding, K 84,037
  • Annual Sales, $ 36,140 K
  • Annual Income, $ -71,450 K
  • 60-Month Beta 2.02
  • Price/Sales 27.48
  • Price/Cash Flow N/A
  • Price/Book 6.71
Trade CRBP with:

Options Overview

Details
  • Implied Volatility 173.52%
  • Historical Volatility 95.75%
  • IV Percentile 51%
  • IV Rank 27.11%
  • IV High 458.14% on 03/12/20
  • IV Low 67.68% on 05/20/20
  • Put/Call Vol Ratio 0.06
  • Today's Volume 3,201
  • Volume Avg (30-Day) 16,091
  • Put/Call OI Ratio 0.17
  • Today's Open Interest 81,442
  • Open Int (30-Day) 92,329

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.23
  • Number of Estimates 4
  • High Estimate -0.15
  • Low Estimate -0.39
  • Prior Year -0.41
  • Growth Rate Est. (year over year) +43.90%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.03 +9.36%
on 02/23/21
4.00 -44.50%
on 02/11/21
-0.47 (-17.47%)
since 02/03/21
3-Month
1.22 +81.97%
on 12/29/20
4.00 -44.50%
on 02/11/21
+0.89 (+66.92%)
since 12/03/20
52-Week
0.91 +143.96%
on 10/30/20
9.78 -77.30%
on 08/31/20
-2.62 (-54.13%)
since 03/03/20

Most Recent Stories

More News
Thinking about buying stock in AMC Entertainment, Nokia, Corbus Pharmaceuticals, GameStop, or Microvision?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AMC, NOK, CRBP, GME, and MVIS.

AC : 35.94 (-1.72%)
CRBP : 2.22 (-4.72%)
MVIS : 15.36 (-9.38%)
AMC : 8.58 (-3.92%)
GME : 124.18 (+5.08%)
NOK : 3.98 (-1.49%)
Cannabis ETF Tops in January: 5 Stocks That Led the Way

Inside the top performing stocks in the top ETF of January.

CRBP : 2.22 (-4.72%)
CGC : 33.24 (-5.70%)
APHA : 18.18 (-4.06%)
TLRY : 25.29 (-2.36%)
HEXO : 7.00 (-4.11%)
POTX : 16.78 (-3.45%)
Should Corbus Pharmaceutical Holdings Be In Your Cannabis Stock Portfolio?

After an unsuccessful clinical trial result sent shares of Corbus Pharmaceuticals Holdings (CRBP) plummeting in September, is now the time to buy? Corbus Pharmaceuticals Holdings Inc. ( CRBP )...

CRBP : 2.22 (-4.72%)
Corbus Pharmaceuticals Announces Presentations at the New York Academy of Sciences Webinar on Targeting the Endocannabinoid System to Treat Human Diseases

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today...

CRBP : 2.22 (-4.72%)
The Little-Known Tech That Could Transform Healthcare

ACB.TO : 13.25 (-4.88%)
STZ : 216.06 (-0.96%)
TLRY : 25.29 (-2.36%)
CRBP : 2.22 (-4.72%)
ACB : 10.46 (-5.17%)
CGC : 33.24 (-5.70%)
CRON : 10.31 (-2.92%)
The Little-Known Tech That Could Transform Healthcare

, /PRNewswire/ -- One under-the-radar company looks to be an absolute game-changer for the healthcare industry. That's because, despite "Big Pharma's" massive resources and staggering amounts of spending,...

ACB.TO : 13.25 (-4.88%)
JUVA.CN : 1.480 (-9.76%)
JUVAF : 1.1531 (-11.71%)
TLRY : 25.29 (-2.36%)
CRBP : 2.22 (-4.72%)
ACB : 10.46 (-5.17%)
CGC : 33.24 (-5.70%)
CRON : 10.31 (-2.92%)
The Little-Known Biotech Company That Is Aiming To Transform Healthcare

One under-the-radar company looks to be an absolute game-changer for the healthcare industry. That’s ...

TLRY : 25.29 (-2.36%)
CRBP : 2.22 (-4.72%)
ACB : 10.46 (-5.17%)
CRON : 10.31 (-2.92%)
N : 90.34 (unch)
Corbus Pharmaceuticals (CRBP) Catches Eye: Stock Jumps 7.3%

Corbus Pharmaceuticals (CRBP) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

CRBP : 2.22 (-4.72%)
ORGO : 15.42 (-3.66%)
Implied Volatility Surging for Corbus Pharmaceuticals (CRBP) Stock Options

Investors need to pay close attention to Corbus Pharmaceuticals (CRBP) stock based on the movements in the options market lately.

CRBP : 2.22 (-4.72%)
Thinking about buying stock in Nantkwest, RealPage, Aerojet Rocketdyne, AIM ImmunoTech, or Corbus Pharmaceuticals?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NK, RP, AJRD, AIM, and CRBP.

AIM : 2.26 (-3.42%)
CRBP : 2.22 (-4.72%)
NK : 26.58 (-6.28%)
RP : 86.87 (-0.23%)
AJRD : 51.84 (+0.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakest short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, lenabasum, is a novel, synthetic...

See More

Key Turning Points

3rd Resistance Point 2.53
2nd Resistance Point 2.46
1st Resistance Point 2.34
Last Price 2.22
1st Support Level 2.15
2nd Support Level 2.08
3rd Support Level 1.96

See More

52-Week High 9.78
Fibonacci 61.8% 6.39
Fibonacci 50% 5.34
Fibonacci 38.2% 4.30
Last Price 2.22
52-Week Low 0.91

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar